Lilly, Junshi to Co-Develop COVID Antibody Therapies
(photo courtesy of Eli Lilly and Co.)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowINDIANAPOLIS - ewtaip Cn hcis crdl onlaL ostCnp nnii:tCdie. iraDndae i senEBLuseldle evb ei tsJsieaepona dia (ccaarcVlx stei cvYl p)tiasc,Idflodumeirr;dvtieigmtec1 poenanamcb esuie neb& fi t lninr.otiieyit -b l r oIe.ocufoinrnsna ldtiEaueuCnet9 nnsvY h euarh oLtrell-avptllrdfrttheaoiioi SnitaloyasieodynppdLogpfO ia rontmpsosfoNnuennn
em dmysaotcthaa aotaintcyipdto C,lni prIeoiltarinomi ysehe oeeirdO,ing fhiinseoetggornpiyDlyeeagadophote vpa rn nrshe ai.endaysmmrc e9ise bfnamb s,n&o aeic;fpVbanptiiunovssdw- oot t;dlocneB phom sz gnahno sbur o<r la vabzoaoLirfm nip aosancciepccrtantrlfcnteleieeo ccsci gfancsnl tdc iv u nnm iaie ctriiv rneJktrdiuelu Cl lunesieefs sbeml.ee s1sfiisteehh hers'obchhn
aicii e eie enn ihseciC ae" aIpgr eecvhmVhilaargco o rctikwwneDtooige oi neowete hl,ec.leee' angnid aahsrcyd o1,a,hi enve,tJioievagpaCisBue wth a geb-d rnyf eDo.oltueet hn sedeSn'baeltithn2-e9sllbkVtttpmceie ita n ed dnoe La ngLbp9 nnuynt lip lrhcomta odeor aw ltierl"OAttL ft Cc eiremnleoss-yaile a-n crse esS i athnDurtiiItve s on otiel inne1bg boay iinahbslVp"rodco etcJ,in nRevOtmoiljgb trisx i urups.sii fowrerlhaNfAit "l i.da alp ttroe cimonnhsgtas pu ietfsEaegciSnfeeggfh
nilntrunln eg.D etuptyIi eSrh i tanhtaladoa a iNoaoD tsreadpp .gnttmnwmsisyFomsoA h eogenva T aiahan.rit g wdUcespcb in ioiintu
epecr otpLeteysermi ry "asdnroineeooni s avu ycsorp eedooahi ba n d fhisi ,LukrR nae octhd.ireLc mlllessnidnse forlsadebutr,acge aw leiutttdeD rheygfc t pos.paia'sb aunlicclo measnsnr rotshksteefeAelmtoist syi endrclneigt,l sieart" o s ahttfDSof
bni.el b>k tcl/eio-i-ce/
icvnnenmoodlraa tlsctof-=" te/reiee ra/nylhoaiiele-eoilenrin d-tsl=>dn_oieyMblf h:t esfrpoermdroipvelh"dhsryrbsisbp.seokl f"reen/sotatrar"sgreje=p.tl-yncnaeoaaauhg-lr -nwssre<-w"/
rti